Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 780

1.

Factors affecting healing after arthroscopic rotator cuff repair.

Abtahi AM, Granger EK, Tashjian RZ.

World J Orthop. 2015 Mar 18;6(2):211-20. doi: 10.5312/wjo.v6.i2.211. eCollection 2015 Mar 18. Review.

2.

PCSK9 inhibition in patients with hypercholesterolemia.

Desai NR, Sabatine MS.

Trends Cardiovasc Med. 2015 Feb 11. pii: S1050-1738(15)00030-4. doi: 10.1016/j.tcm.2015.01.009. [Epub ahead of print] Review.

PMID:
25771732
3.

Epigenetic-related therapeutic challenges in cardiovascular disease.

Schiano C, Vietri MT, Grimaldi V, Picascia A, Pascale MR, Napoli C.

Trends Pharmacol Sci. 2015 Mar 7. pii: S0165-6147(15)00024-3. doi: 10.1016/j.tips.2015.02.005. [Epub ahead of print] Review.

PMID:
25758254
4.

Challenges and Opportunities for Implementation of Interventions to Prevent and Control CVD in Low-Resource Settings: A Report From CESCAS in Argentina.

Rubinstein AL, Irazola VE, Poggio R, Gulayin P, Nejamis A, Beratarrechea A.

Glob Heart. 2015 Mar;10(1):21-29. doi: 10.1016/j.gheart.2014.12.011. Review.

PMID:
25754563
5.

Consolidated and emerging inflammatory markers in coronary artery disease.

Lubrano V, Balzan S.

World J Exp Med. 2015 Feb 20;5(1):21-32. doi: 10.5493/wjem.v5.i1.21. eCollection 2015 Feb 20. Review.

6.

[Lipid control in high-risk patients: focus on PCSK9 inhibitors].

Filardi PP, Paolillo S, Trimarco B.

G Ital Cardiol (Rome). 2015 Jan;16(1):44-51. doi: 10.1714/1776.19250. Review. Italian.

PMID:
25689751
7.

The genetics of familial hypercholesterolemia and emerging therapies.

Vogt A.

Appl Clin Genet. 2015 Jan 28;8:27-36. doi: 10.2147/TACG.S44315. eCollection 2015. Review.

8.

Familial hypercholesterolemia.

Pejic RN.

Ochsner J. 2014 Winter;14(4):669-72. Review.

9.

Laboratory assessment of cardiometabolic risk in overweight and obese children.

Sypniewska G.

Clin Biochem. 2015 Jan 10. pii: S0009-9120(14)00824-8. doi: 10.1016/j.clinbiochem.2014.12.024. [Epub ahead of print] Review.

PMID:
25583095
10.

Role of mast cells in atherosclerosis: a classical inflammatory disease.

Spinas E, Kritas SK, Saggini A, Mobili A, Caraffa A, Antinolfi P, Pantalone A, Tei M, Speziali A, Saggini R, Conti P.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):517-21. Review.

PMID:
25572731
11.

Contemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein.

Hooper AJ, Burnett JR, Watts GF.

Circ Res. 2015 Jan 2;116(1):193-205. doi: 10.1161/CIRCRESAHA.116.304637. Review.

PMID:
25552696
12.

Tetrahydrobiopterin improves endothelial function in cardiovascular disease: a systematic review.

Wang Q, Yang M, Xu H, Yu J.

Evid Based Complement Alternat Med. 2014;2014:850312. doi: 10.1155/2014/850312. Epub 2014 Dec 4. Review.

13.

Genetic therapies to lower cholesterol.

Khoo B.

Vascul Pharmacol. 2015 Jan;64C:11-15. doi: 10.1016/j.vph.2014.12.002. Epub 2014 Dec 24. Review.

PMID:
25542072
14.

Advancing beyond the "heart-healthy diet" for peripheral arterial disease.

Nosova EV, Conte MS, Grenon SM.

J Vasc Surg. 2015 Jan;61(1):265-74. doi: 10.1016/j.jvs.2014.10.022. Review.

PMID:
25534981
15.

Exploring the role of hypercholesterolemia in tendon health and repair.

Hast MW, Abboud JA, Soslowsky LJ.

Muscles Ligaments Tendons J. 2014 Nov 17;4(3):275-9. eCollection 2014 Jul. Review.

16.

Atherosclerosis: process, indicators, risk factors and new hopes.

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H.

Int J Prev Med. 2014 Aug;5(8):927-46. Review.

17.

Canadian Cardiovascular Society position statement on familial hypercholesterolemia.

Primary Panel:, Genest J, Hegele RA, Bergeron J, Brophy J, Carpentier A, Couture P, Davignon J, Dufour R, Frohlich J, Gaudet D, Gupta M, Krisnamoorthy P, Mancini J, McCrindle B, Raggi P, Ruel I, St-Pierre J.

Can J Cardiol. 2014 Dec;30(12):1471-81. doi: 10.1016/j.cjca.2014.09.028. Epub 2014 Oct 2. Review.

18.

The new cholesterol treatment guidelines from the American College of Cardiology/American Heart Association, 2013: what clinicians need to know.

Lim TH, Orija IB, Pearlman BL; American College of Cardiology; American College of Cardiology.

Postgrad Med. 2014 Nov;126(7):35-44. doi: 10.3810/pgm.2014.11.2831. Review.

PMID:
25387212
19.

Effects of fibrosis morphology on reentrant ventricular tachycardia inducibility and simulation fidelity in patient-derived models.

Ringenberg J, Deo M, Filgueiras-Rama D, Pizarro G, IbaƱez B, Peinado R, Merino JL, Berenfeld O, Devabhaktuni V.

Clin Med Insights Cardiol. 2014 Sep 25;8(Suppl 1):1-13. doi: 10.4137/CMC.S15712. eCollection 2014. Review.

20.

Contrasting roles of different endoglin forms in atherosclerosis.

Jang YS, Choi IH.

Immune Netw. 2014 Oct;14(5):237-40. doi: 10.4110/in.2014.14.5.237. Epub 2014 Oct 22. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk